ReportLinker
Abstract: What`s New for 2022? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.
New York, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Hormone Replacement Therapy (HRT) Industry" - https://www.reportlinker.com/p05961363/?utm_source=GNW Online interactive peer-to-peer collaborative bespoke updatesAccess to our digital archives and MarketGlass Research PlatformComplimentary updates for one year
Global Hormone Replacement Therapy (HRT) Market to Reach $40.5 Billion by 2027
Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$26.6 Billion in the year 2020, is projected to reach a revised size of US$40.5 Billion by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is projected to record a 6.3% CAGR and reach US$22.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Human Growth Hormone Replacement Therapy segment is readjusted to a revised 7.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $7.8 Billion, While China is Forecast to Grow at 5.8% CAGR
The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.1 Billion by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
Testosterone Hormone Replacement Therapy Segment to Record 5.3% CAGR
In the global Testosterone Hormone Replacement Therapy segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.7 Billion in the year 2020 will reach a projected size of US$5.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.7 Billion by the year 2027.
Select Competitors (Total 47 Featured) - Abbott LaboratoriesAllergan PlcBayer AGNovartis AGNoven Pharmaceuticals Inc.Novo Nordisk A/SPfizer Inc.TherapeuticsMD Inc.
Read the full report: https://www.reportlinker.com/p05961363/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEWInfluencer Market InsightsWorld Market TrajectoriesImpact of Covid-19 and a Looming Global RecessionAn Introduction to Menopause and Hormone Replacement TherapyRecent Market ActivityThe HRT Controversy - An InsightNewer Studies Challenge WHI Findings and Re-establish Safety ofHRTRevised Recommendations of the NAMS and Endocrine SocietyIMS Consensus Guidelines Paving Way for More Clarity of HRTThe Regional DivideIncreasing Number of Menopausal Women - A Major Market DriverNew Bioidentical Drugs Serve Unmet Market NeedsGeneric Incursion in Hormone Replacement Therapy - List ofDrugs With and Without Approved Generic VersionsIntense Competition Marks the Global HRT MarketThe Premarin SagaEstrace Cream Drives Revenue Gains in Allergan?s HRT PortfolioHormone Replacement Therapy (HRT) - Global Key CompetitorsPercentage Market Share in 2022 (E)Competitive Market Presence - Strong/Active/Niche/Trivial forPlayers Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERSAbbott Laboratories (USA)Allergan Plc (Ireland)Bayer AG (Germany)Noven Pharmaceuticals, Inc. (USA)Novartis AG(Switzerland)Novo Nordisk A/S (Denmark)Orion Pharma AB (Finland)Pfizer, Inc. (USA)TherapeuticsMD, Inc. (USA)
3. MARKET TRENDS & DRIVERSUnmet Needs in Combination Therapies for HRT drive Research forNew MedicinesTopical Estrogens - More Safe and EffectiveTransdermal HRT Products Present Exciting OpportunitiesPhytoestrogens - The New Panacea for Menopausal Symptoms?Diet Link to Menopause Symptoms Raises InterestImpact of Soy and Other Phytoestrogens - A Reality CheckEstroG - A Successful Herbal Health Supplement in AlleviatingMenopausal SymptomsThe Growing Buzz around Bioidentical DrugsBio-identical Hormones - A Natural and Safe Substitute toSynthetic HRT?Pellet Therapy - A New Innovation Downsizes Conventional Issueswith Bioidentical HRTDirect-to-Consumer Advertising for HRT - A Mixed BagEstriol: The Next Generation Estrogen Therapy?What Makes Estriol Work?Topical Estriol - More Promising in SafetyEstriol - Used More Commonly Outside the USEntry of Generics Threatens Market Growth ProspectsAre Non-Hormonal Therapies A Threat to HRT?Earlier Failures Induce Lethargy in Non-Hormonal Therapies
4. GLOBAL MARKET PERSPECTIVETable 1: World Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Geographic Region - USA,Canada, Japan, China, Europe, Asia-Pacific and Rest of WorldMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Hormone Replacement Therapy(HRT) by Geographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World Markets - Independent Analysisof Annual Sales in US$ Million for Years 2012 through 2019 and% CAGR
Table 3: World 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Geographic Region - Percentage Breakdown ofValue Sales for USA, Canada, Japan, China, Europe, Asia-Pacificand Rest of World Markets for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis forEstrogen Hormone Replacement Therapy by Geographic Region -USA, Canada, Japan, China, Europe, Asia-Pacific and Rest ofWorld Markets - Independent Analysis of Annual Sales in US$Million for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Estrogen Hormone ReplacementTherapy by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific and Rest of World Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2012 through2019 and % CAGR
Table 6: World 15-Year Perspective for Estrogen HormoneReplacement Therapy by Geographic Region - Percentage Breakdownof Value Sales for USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for HumanGrowth Hormone Replacement Therapy by Geographic Region - USA,Canada, Japan, China, Europe, Asia-Pacific and Rest of WorldMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Human Growth HormoneReplacement Therapy by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific and Rest of World Markets -Independent Analysis of Annual Sales in US$ Million for Years2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Human Growth HormoneReplacement Therapy by Geographic Region - Percentage Breakdownof Value Sales for USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis forTestosterone Hormone Replacement Therapy by Geographic Region -USA, Canada, Japan, China, Europe, Asia-Pacific and Rest ofWorld Markets - Independent Analysis of Annual Sales in US$Million for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Testosterone HormoneReplacement Therapy by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific and Rest of World Markets -Independent Analysis of Annual Sales in US$ Million for Years2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Testosterone HormoneReplacement Therapy by Geographic Region - Percentage Breakdownof Value Sales for USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis forThyroid Hormone Replacement Therapy by Geographic Region - USA,Canada, Japan, China, Europe, Asia-Pacific and Rest of WorldMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Thyroid Hormone ReplacementTherapy by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific and Rest of World Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2012 through2019 and % CAGR
Table 15: World 15-Year Perspective for Thyroid HormoneReplacement Therapy by Geographic Region - Percentage Breakdownof Value Sales for USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis forMenopause by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific and Rest of World Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2020 through2027 and % CAGR
Table 17: World Historic Review for Menopause by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific andRest of World Markets - Independent Analysis of Annual Sales inUS$ Million for Years 2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Menopause by GeographicRegion - Percentage Breakdown of Value Sales for USA, Canada,Japan, China, Europe, Asia-Pacific and Rest of World for Years2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for MaleHypogonadism by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific and Rest of World Markets - IndependentAnalysis of Annual Sales in US$ Million for Years 2020 through2027 and % CAGR
Table 20: World Historic Review for Male Hypogonadism byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World Markets - Independent Analysisof Annual Sales in US$ Million for Years 2012 through 2019 and% CAGR
Table 21: World 15-Year Perspective for Male Hypogonadism byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific and Rest ofWorld for Years 2012, 2021 & 2027
Table 22: World Recent Past, Current & Future Analysis forGrowth Hormone Deficiency by Geographic Region - USA, Canada,Japan, China, Europe, Asia-Pacific and Rest of World Markets -Independent Analysis of Annual Sales in US$ Million for Years2020 through 2027 and % CAGR
Table 23: World Historic Review for Growth Hormone Deficiencyby Geographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World Markets - Independent Analysisof Annual Sales in US$ Million for Years 2012 through 2019 and% CAGR
Table 24: World 15-Year Perspective for Growth HormoneDeficiency by Geographic Region - Percentage Breakdown of ValueSales for USA, Canada, Japan, China, Europe, Asia-Pacific andRest of World for Years 2012, 2021 & 2027
Table 25: World Recent Past, Current & Future Analysis forHypothyroidism by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific and Rest of World Markets -Independent Analysis of Annual Sales in US$ Million for Years2020 through 2027 and % CAGR
Table 26: World Historic Review for Hypothyroidism byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World Markets - Independent Analysisof Annual Sales in US$ Million for Years 2012 through 2019 and% CAGR
Table 27: World 15-Year Perspective for Hypothyroidism byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific and Rest ofWorld for Years 2012, 2021 & 2027
Table 28: World Recent Past, Current & Future Analysis forOther Type of Diseases by Geographic Region - USA, Canada,Japan, China, Europe, Asia-Pacific and Rest of World Markets -Independent Analysis of Annual Sales in US$ Million for Years2020 through 2027 and % CAGR
Table 29: World Historic Review for Other Type of Diseases byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific and Rest of World Markets - Independent Analysisof Annual Sales in US$ Million for Years 2012 through 2019 and% CAGR
Table 30: World 15-Year Perspective for Other Type of Diseasesby Geographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific and Rest ofWorld for Years 2012, 2021 & 2027
Table 31: World Hormone Replacement Therapy (HRT) MarketAnalysis of Annual Sales in US$ Million for Years 2012 through2027
III. MARKET ANALYSIS
UNITED STATESHormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Statesfor 2022 (E)Table 32: USA Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 33: USA Historic Review for Hormone Replacement Therapy(HRT) by Product - Estrogen Hormone Replacement Therapy, HumanGrowth Hormone Replacement Therapy, Testosterone HormoneReplacement Therapy and Thyroid Hormone Replacement TherapyMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 34: USA 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 35: USA Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 36: USA Historic Review for Hormone Replacement Therapy(HRT) by Type of Disease - Menopause, Male Hypogonadism, GrowthHormone Deficiency, Hypothyroidism and Other Type of DiseasesMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 37: USA 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
CANADATable 38: Canada Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 39: Canada Historic Review for Hormone ReplacementTherapy (HRT) by Product - Estrogen Hormone ReplacementTherapy, Human Growth Hormone Replacement Therapy, TestosteroneHormone Replacement Therapy and Thyroid Hormone ReplacementTherapy Markets - Independent Analysis of Annual Sales in US$Million for Years 2012 through 2019 and % CAGR
Table 40: Canada 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 41: Canada Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 42: Canada Historic Review for Hormone ReplacementTherapy (HRT) by Type of Disease - Menopause, MaleHypogonadism, Growth Hormone Deficiency, Hypothyroidism andOther Type of Diseases Markets - Independent Analysis of AnnualSales in US$ Million for Years 2012 through 2019 and % CAGR
Table 43: Canada 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
JAPANHormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)Table 44: Japan Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 45: Japan Historic Review for Hormone Replacement Therapy(HRT) by Product - Estrogen Hormone Replacement Therapy, HumanGrowth Hormone Replacement Therapy, Testosterone HormoneReplacement Therapy and Thyroid Hormone Replacement TherapyMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 46: Japan 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 47: Japan Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 48: Japan Historic Review for Hormone Replacement Therapy(HRT) by Type of Disease - Menopause, Male Hypogonadism, GrowthHormone Deficiency, Hypothyroidism and Other Type of DiseasesMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 49: Japan 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
CHINAHormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)Table 50: China Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 51: China Historic Review for Hormone Replacement Therapy(HRT) by Product - Estrogen Hormone Replacement Therapy, HumanGrowth Hormone Replacement Therapy, Testosterone HormoneReplacement Therapy and Thyroid Hormone Replacement TherapyMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 52: China 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 53: China Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 54: China Historic Review for Hormone Replacement Therapy(HRT) by Type of Disease - Menopause, Male Hypogonadism, GrowthHormone Deficiency, Hypothyroidism and Other Type of DiseasesMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 55: China 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
EUROPEHormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)Table 56: Europe Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Geographic Region -France, Germany, Italy, UK and Rest of Europe Markets -Independent Analysis of Annual Sales in US$ Million for Years2020 through 2027 and % CAGR
Table 57: Europe Historic Review for Hormone ReplacementTherapy (HRT) by Geographic Region - France, Germany, Italy, UKand Rest of Europe Markets - Independent Analysis of AnnualSales in US$ Million for Years 2012 through 2019 and % CAGR
Table 58: Europe 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Geographic Region - Percentage Breakdown ofValue Sales for France, Germany, Italy, UK and Rest of EuropeMarkets for Years 2012, 2021 & 2027
Table 59: Europe Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 60: Europe Historic Review for Hormone ReplacementTherapy (HRT) by Product - Estrogen Hormone ReplacementTherapy, Human Growth Hormone Replacement Therapy, TestosteroneHormone Replacement Therapy and Thyroid Hormone ReplacementTherapy Markets - Independent Analysis of Annual Sales in US$Million for Years 2012 through 2019 and % CAGR
Table 61: Europe 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 62: Europe Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 63: Europe Historic Review for Hormone ReplacementTherapy (HRT) by Type of Disease - Menopause, MaleHypogonadism, Growth Hormone Deficiency, Hypothyroidism andOther Type of Diseases Markets - Independent Analysis of AnnualSales in US$ Million for Years 2012 through 2019 and % CAGR
Table 64: Europe 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
FRANCEHormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)Table 65: France Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 66: France Historic Review for Hormone ReplacementTherapy (HRT) by Product - Estrogen Hormone ReplacementTherapy, Human Growth Hormone Replacement Therapy, TestosteroneHormone Replacement Therapy and Thyroid Hormone ReplacementTherapy Markets - Independent Analysis of Annual Sales in US$Million for Years 2012 through 2019 and % CAGR
Table 67: France 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 68: France Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 69: France Historic Review for Hormone ReplacementTherapy (HRT) by Type of Disease - Menopause, MaleHypogonadism, Growth Hormone Deficiency, Hypothyroidism andOther Type of Diseases Markets - Independent Analysis of AnnualSales in US$ Million for Years 2012 through 2019 and % CAGR
Table 70: France 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
GERMANYHormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)Table 71: Germany Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 72: Germany Historic Review for Hormone ReplacementTherapy (HRT) by Product - Estrogen Hormone ReplacementTherapy, Human Growth Hormone Replacement Therapy, TestosteroneHormone Replacement Therapy and Thyroid Hormone ReplacementTherapy Markets - Independent Analysis of Annual Sales in US$Million for Years 2012 through 2019 and % CAGR
Table 73: Germany 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 74: Germany Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 75: Germany Historic Review for Hormone ReplacementTherapy (HRT) by Type of Disease - Menopause, MaleHypogonadism, Growth Hormone Deficiency, Hypothyroidism andOther Type of Diseases Markets - Independent Analysis of AnnualSales in US$ Million for Years 2012 through 2019 and % CAGR
Table 76: Germany 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
ITALYTable 77: Italy Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Table 78: Italy Historic Review for Hormone Replacement Therapy(HRT) by Product - Estrogen Hormone Replacement Therapy, HumanGrowth Hormone Replacement Therapy, Testosterone HormoneReplacement Therapy and Thyroid Hormone Replacement TherapyMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 79: Italy 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Product - Percentage Breakdown of Value Salesfor Estrogen Hormone Replacement Therapy, Human Growth HormoneReplacement Therapy, Testosterone Hormone Replacement Therapyand Thyroid Hormone Replacement Therapy for the Years 2012,2021 & 2027
Table 80: Italy Recent Past, Current & Future Analysis forHormone Replacement Therapy (HRT) by Type of Disease -Menopause, Male Hypogonadism, Growth Hormone Deficiency,Hypothyroidism and Other Type of Diseases - IndependentAnalysis of Annual Sales in US$ Million for the Years 2020through 2027 and % CAGR
Table 81: Italy Historic Review for Hormone Replacement Therapy(HRT) by Type of Disease - Menopause, Male Hypogonadism, GrowthHormone Deficiency, Hypothyroidism and Other Type of DiseasesMarkets - Independent Analysis of Annual Sales in US$ Millionfor Years 2012 through 2019 and % CAGR
Table 82: Italy 15-Year Perspective for Hormone ReplacementTherapy (HRT) by Type of Disease - Percentage Breakdown ofValue Sales for Menopause, Male Hypogonadism, Growth HormoneDeficiency, Hypothyroidism and Other Type of Diseases for theYears 2012, 2021 & 2027
UNITED KINGDOMHormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdomfor 2022 (E)Table 83: UK Recent Past, Current & Future Analysis for HormoneReplacement Therapy (HRT) by Product - Estrogen HormoneReplacement Therapy, Human Growth Hormone Replacement Therapy,Testosterone Hormone Replacement Therapy and Thyroid HormoneReplacement Therapy - Independent Analysis of Annual Sales inUS$ Million for the Years 2020 through 2027 and % CAGR
Read more:
Global Hormone Replacement Therapy (HRT) Market to Reach $40.5 Billion by 2027 - Yahoo Finance UK
